Results 61 to 70 of about 99,753 (275)

Two cases of angioimmunoblastic T-cell lymphoma with concomitant positive serology for acute Epstein-Barr virus infection

Hematology Reports, 2017
Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of peripheral T-cell lymphoma. Epstein-Barr virus (EBV) is known to be associated with pathogenesis and histological progression of AITL and the onset of the disease often mimics an infectious ...
Davide Facchinelli, Angela Polino, Francesco Dima, Alice Parisi, Achille Ambrosetti, Dino Veneri   +5 more
doaj   +1 more source

Overlap between EBV‐positive diffuse large B‐cell lymphoma, NOS, in a young patient and angioimmunoblastic T‐cell lymphoma: A diagnostic pitfall

Clinical Case Reports, 2021
There may be significant histopathologic overlap between EBV‐positive DLBCL, NOS, and other diagnoses including angioimmunoblastic T‐cell lymphoma (AITL).
Chae Hwa Kim, Taban Ghaffaripour, Yi Zhou, Jennifer R. Chapman   +3 more
doaj   +1 more source

The curious origins of angioimmunoblastic T-cell lymphoma [PDF]

Current Opinion in Hematology, 2016
Purpose of review Once an obscure disease, recent studies have transformed our understanding of angioimmunoblastic T-cell lymphoma (AITL). In this review, we summarize new major advances in the genetics and biology of AITL.
Teresa Palomero, Jose R. Cortes
openaire   +2 more sources

Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking

eLife, 2021
Background: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS ...
Shuhua Cheng, Wei Zhang, G. Inghirami, W. Tam   +3 more
semanticscholar   +1 more source

Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma [PDF]

, 2018
Angioimmunoblastic T‐cell lymphoma (AITL) is a subtype of nodal peripheral T‐cell lymphoma (PTCL). Somatic RHOA mutations, most frequently found at the hotspot site c.50G > T, p.Gly17Val (G17V RHOA mutation) are a genetic hallmark of AITL.
Chiba Shigeru, Fujisawa Manabu, Fukumoto Kota, Hattori Keiichiro, Komori Daisuke, Kusakabe Manabu, Matsue Kosei, Sakata-Yanagimoto Mamiko, Shimadzu Mitsunobu, Suehara Yasuhito, Tanzima Nuhat Sharna, Wakamatsu Hirotake, 千葉 滋, 坂田（柳元） 麻実子, 日下部 学, 服部 圭一朗   +15 more
core   +2 more sources

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

Frontiers in Medicine, 2021
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid
S. Goldman, D. Bron, T. Tousseyn, I. Vierasu, Laurent Dewispelaere, P. Heimann, E. Cogan, Michel Goldman   +7 more
semanticscholar   +1 more source

Not your typical morbilliform rash: Angioimmunoblastic T‐cell lymphoma

Clinical Case Reports, 2021
Angioimmunoblastic T‐cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug‐induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear
Wendi Bao, Kendall L. Buchanan, Loretta S. Davis   +2 more
doaj   +1 more source

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study [PDF]

, 2013
PURPOSE: The differential diagnosis among the commonest peripheral T-cell lymphomas (PTCLs; ie, PTCL not otherwise specified [NOS], angioimmunoblastic T-cell lymphoma [AITL], and anaplastic large-cell lymphoma [ALCL]) is difficult, with the morphologic ...
Agostinelli, C., Bacci, F., Bellei, Monica, Bertuzzi, C., Chan, J. C., De Leo, A., Federico, Massimo, Fuligni, F., Gazzola, A., Hansmann, M. L., Hartmann, S., Inghirami, G., Iqbal, J., Laginestra, M. A., Mannu, C., Piccaluga, P. P., Pileri, S. A., Piva, R., Rossi, M., Sabattini, E., Sapienza, M. R., Vose, J. M., Weisenburger, D., Zinzani, P. L.   +23 more
core   +1 more source

Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant

British Journal of Haematology, 2022
There have been no large studies comparing reduced‐intensity/non‐myeloablative conditioning (RIC/NMA) to myeloablative conditioning (MAC) regimens in T‐cell non‐Hodgkin lymphoma (T‐NHL) patients undergoing allogeneic transplant (allo‐HCT). A total of 803
M. Savani, K. Ahn, Yue Chen, Saira S. Ahmed, A. Cashen, M. Shadman, D. Modi, F. Khimani, C. Cutler, J. Zain, J. Brammer, Andrew R. Rezvani, T. Fenske, C. Sauter, M. Kharfan-Dabaja, A. Herrera, M. Hamadani   +16 more
semanticscholar   +1 more source

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma

Acta Dermato-Venereologica, 2021
is missing (Short communication)
Shoko Hattori, Fumi Miyagawa, Keiko Fukuda, Kohei Ogawa, Hideo Asada   +4 more
doaj   +1 more source